The Safety of Dapagliflozin in Hemodialysis Patients With Heart Failure

Clinical trial NCT05141552 · UNKNOWN

Trial details

NCT number: NCT05141552
Sponsor: RenJi Hospital
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Hemodialysis Complication

Start date: 2022-01-03
Primary completion: 2022-07-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.